MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 30.03.2026
Precipio Langfristiger Schuldenstrom 2011-2026 | PRPO
Langfristiger Schuldenstrom Jährlich Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 410 K | 201 K | 218 K | 199 K | 166 K | 225 K | 209 K | 263 K | 587 K | 7.81 M | 7.6 M | 462 K | 242 K | 6.17 M | 3.7 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.81 M | 166 K | 1.9 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
697 K | $ 1.19 | 1.71 % | $ 6.48 M | USA |
 |
Co-Diagnostics
CODX
|
662 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 24.96 | 0.52 % | $ 693 M | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.9 | -0.06 % | $ 481 M | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Danaher Corporation
DHR
|
199 M | $ 196.79 | 3.03 % | $ 140 B | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 1.91 | -4.44 % | $ 8.45 M | USA |
 |
Illumina
ILMN
|
79 M | $ 128.88 | 1.93 % | $ 20.5 B | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 17.85 | 1.02 % | $ 951 M | USA |
 |
Guardant Health
GH
|
27.7 M | $ 93.45 | 0.16 % | $ 11.7 B | USA |
 |
DexCom
DXCM
|
21.6 M | $ 65.61 | 3.96 % | $ 25.6 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 275.56 | 2.37 % | $ 22.9 B | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 80.03 | 2.5 % | $ 5.4 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 324.02 | 4.25 % | $ 27.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 108.01 | 0.79 % | $ 8.91 B |  Irlanda |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.75 | 0.11 % | $ 440 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Natera
NTRA
|
7.64 M | $ 212.17 | 1.38 % | $ 20.9 B | USA |
 |
Pacific Biosciences of California
PACB
|
448 K | $ 1.46 | 1.04 % | $ 438 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.99 | 3.63 % | $ 20 B |  Niderland |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Personalis
PSNL
|
7.7 M | $ 6.41 | 3.89 % | $ 380 M | USA |
 |
RadNet
RDNT
|
61.9 M | $ 56.08 | 2.75 % | $ 4.22 B | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 175.71 | 3.64 % | $ 8.71 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K |  Israel |
 |
Senseonics Holdings
SENS
|
496 K | $ 6.6 | -2.37 % | $ 275 M | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 503.51 | 2.88 % | $ 190 B | USA |
 |
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | USA |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 51.68 | 3.11 % | $ 3.09 B | USA |
 |
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B | USA |
 |
Quotient Limited
QTNT
|
3.45 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Waters Corporation
WAT
|
31.1 M | $ 320.56 | 4.29 % | $ 19.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Exagen
XGN
|
1.23 M | $ 3.08 | 2.5 % | $ 66.4 M | USA |